Prospective longitudinal study of corneal collagen cross-linking in progressive keratoconus

Clinical and Experimental Ophthalmology

Volumn 41, Issue 6, 2013, Pages 531-536

  Viswanathan, Deepa ^a   Males, John ^a,b,c  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Collagen cross linking; Keratoconus; Maximum keratometry

Indexed keywords

COLLAGEN; DEXTRAN; RIBOFLAVIN;

ADOLESCENT; ADULT; ARTICLE; CENTRAL CORNEAL THICKNESS; CLINICAL ARTICLE; COLLAGEN CROSS LINKAGE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERVENTION STUDY; KERATOCONUS; KERATOMETRY; LONGITUDINAL STUDY; MALE; PROGRESSIVE KERATOCONUS; PROSPECTIVE STUDY; PROTEIN CROSS LINKING; ULTRAVIOLET A RADIATION; VISUAL ACUITY;

COLLAGEN CROSS-LINKING; KERATOCONUS; MAXIMUM KERATOMETRY;

ADOLESCENT; ADULT; COLLAGEN; CORNEAL PACHYMETRY; CORNEAL STROMA; CROSS-LINKING REAGENTS; DISEASE PROGRESSION; FEMALE; HUMANS; KERATOCONUS; LONGITUDINAL STUDIES; MALE; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; REFRACTION, OCULAR; RIBOFLAVIN; ULTRAVIOLET RAYS; VISUAL ACUITY; YOUNG ADULT;

EID: 84881085732     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12035     Document Type: Article

References (36)

1. Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998; 42: 297-319.
2. Ertan A, Muftuoglu O. Keratoconus: clinical findings according to different age and gender groups. Cornea 2008; 27: 1109-1113.
3. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol 1986; 101: 267-273.
4. Tuft SJ, Moodaley LC, Gregory WM, Davison CR, Buckley RJ. Prognostic factors for the progression of keratoconus. Ophthalmology 1994; 101: 439-447.
5. The Australian Corneal Graft Registry. 1990 to 1992 report. Aust N Z J Ophthalmol 1993; 21: 1-48.
6. Kanavi MR, Javadi MA, Sanagoo M. Indications for penetrating keratoplasty in Iran. Cornea 2007; 26: 561-563.
7. Kang PC, Klintworth GK, Kim T etal. Trends in the indications for penetrating keratoplasty, 1980-2001. Cornea 2005; 24: 801-803.
8. Radner W, Zehemayer M, Skorpik C, Mallinger R. Altered organization of collagen in apex of keratoconus corneas. Ophthalmic Res 1998; 30: 327-332.
9. Andreasson TT, Simonsen AH, Oxlund H. Biomechanical properties of keratoconus and normal corneas. Exp Eye Res 1980; 31: 435-441.
10. Kenney MC, Nesburn AB, Burgeson RE etal. Abnormalities of the extracellular matrix in keratoconus corneas. Cornea 1997; 16: 345-351.
11. Daxer A, Fratzl P. Collagen fibril orientation in the human corneal stroma and its implication in keratoconus. Invest Ophthalmol Vis Sci 1997; 38: 121-129.
12. Meek KM, Tuft SJ, Huang Y etal. Changes in collagen orientation and distribution in keratoconus corneas. Invest Ophthalmol Vis Sci 2005; 46: 1948-1956.
13. Rehany U, Lahav M, Shoshan S. Collagenolytic activity in keratoconus. Ann Ophthalmol 1982; 14: 751-754.
14. Sawaguchi S, Yue BYJT, Chang I etal. Proteoglycan molecules in keratoconus corneas. Invest Ophthalmol Vis Sci 1991; 32: 1846-1853.
15. Wollensak J, Buddecke E. Biochemical studies on human corneal proteoglycans - a comparison of normal and keratoconic eyes. Graefes Arch Clin Exp Ophthalmol 1990; 228: 517-523.
16. Sawaguchi S, Yue BYJT, Sugar J, Gilboy J. Lysosomal enzyme abnormalities in keratoconus. Arch Ophthalmol 1989; 107: 1507-1510.
17. Zhou L, Sawaguchi S, Twining SS etal. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci 1998; 39: 1117-1124.
18. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 2006; 17: 356-360.
19. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg 2003; 29: 1780-1785.
20. Kohlhaas M, Spoerl E, Schilde T etal. Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light. J Cataract Refract Surg 2006; 32: 279-283.
21. Wollensak G, Wilsch M, Spoerl E etal. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA. Cornea 2004; 23: 503-507.
22. Caporossi A, Baiocchi S, Mazzotta C etal. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A induced cross-linking of corneal collagen: preliminary refractive results in an Italian study. J Cataract Refract Surg 2006; 32: 837-845.
23. Hoyer A, Raiskup-Wolf F, Spörl E etal. Collagen cross-linking with riboflavin and UVA light in keratoconus. Results from Dresden. (in German) Ophthalmologe 2009; 106: 133-140.
24. Wittig-Silva C, Whiting M, Lamoureux E etal. A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. J Cataract Refract Surg 2008; 24: S720-725.
25. Jankov MR 2nd, Hafezi F, Beko M etal. Corneal cross-linking for the treatment of keratoconus: preliminary results. (in Portuguese) Arq Bras Oftalmol 2008; 71: 813-818.
26. Vinciguerra P, Albè E, Trazza S etal. Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking. Ophthalmology 2009; 116: 369-378.
27. Agrawal VB. Corneal collagen cross-linking with riboflavin and ultraviolet-A light for keratoconus: results in Indian eyes. Indian J Ophthalmol 2009; 57: 111-114.
28. Grewal DS, Brar GS, Jain R, Sood V, Singla M, Grewal SPS. Corneal collagen crosslinking using riboflavin and ultraviolet-A light for keratoconus: one-year analysis using Scheimpflug imaging. J Cataract Refract Surg 2009; 35: 425-432.
29. Caporossi A, Mazzotta C, Baiocchi S, Caparossi T. Long-term results of riboflavin ultraviolet A corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. Am J Ophthalmol 2010; 149: 585-593.
30. Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg 2008; 34: 796-801.
31. O'Brart DPS, Chan E, Samaras K, Patel P, Shah SP. A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370nm) corneal collagen cross-linkage to halt the progression of keratoconus. Br J Ophthalmol 2011; 95: 1519-1524.
32. Krumeich JH, Daniel J. Live epikeratophakia and deep lamellar keratoplasty for I-III stage specific surgical treatment of keratoconus. Klin Monatsbl Augenheilkd 1997; 211: 94-100.
33. McAlinden C, Khadka J, Pesudovs K. A comprehensive evaluation of the precision (repeatability and reproducibility) of the Oculus Pentacam HR. Invest Ophthalmol Vis Sci 2011; 52: 7731-7737.
34. Kawamorita T, Uozato H, Kamiya K etal. Repeatability, reproducibility and agreement characteristics of rotating Scheimpflug photography and scanning-slit corneal topography for corneal power measurement. J Cataract Refract Surg 2009; 35: 127-133.
35. Hersh PS, Greenstein SA, Fry KL etal. Corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg 2011; 37: 149-160.
36. Asri D, Touboul D, Fourni P etal. Corneal collagen crosslinking in progressive keratoconus: multicenter results from the French National Reference Center for Keratoconus. J Cataract Refract Surg 2011; 37: 2137-2143.